Intravascular embolizing agent containing angiogenesis-inhibiting substance
US5202352A · kind A · utility
152Cited by
2References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 6, 1991 |
| Grant date | Apr 13, 1993 |
| Priority date | — |
| Expiry date | Aug 6, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to an intravascular embolizing agent containing an angiogenesis-inhibiting substance and an intravascular embolizing substance. The agent strengthens the antitumor effect of an angiogenesis-inhibiting substance and serves to reduce the dose and undesirable side effects. And use of the agent in concert with an anti-neoplastic agent brings about further strong and long-lasting antitumor effects.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.